Ricardo Rodrïguez-Calvo Selected Research

Peroxisome Proliferator-Activated Receptors (PPAR)

1/2009

Peroxisome proliferator-activated receptor (PPAR) beta/delta: a new potential therapeutic target for the treatment of metabolic syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ricardo Rodrïguez-Calvo Research Topics

Disease

1	Type 2 Hdl Deficiency 01/2009
1	Hypertension (High Blood Pressure) 01/2009
1	Inflammation (Inflammations) 01/2009
1	Insulin Resistance 01/2009
1	Hypertriglyceridemia 01/2009
1	Weight Gain 01/2009
1	Glucose Intolerance 01/2009
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2009
1	Dyslipidemias (Dyslipidemia) 01/2009
1	Abdominal Obesity 01/2009

Drug/Important Bio-Agent (IBA)

1	LigandsIBA 01/2009
1	LipidsIBA 01/2009
1	Triglycerides (Triacylglycerol)IBA 01/2009
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2009
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2009
1	PPAR alphaIBA 01/2009
1	PPAR gammaIBA 01/2009
1	PPAR-betaIBA 01/2009